Pediatric cancers have a huge survival gap between the high-income and the low-middle-income countries (LMICs).
Despite various other causes, the advanced stage of presentation is a major contributing factor but limited data is available from developing countries in this regard.
This study aimed to identify delay in treatment and factors associated with it in our setup.
